ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2017. The put-call ratio across all filers is 3.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $361,000 | +30.3% | 5,000 | +19.0% | 0.11% | +29.4% |
| Q4 2017 | $277,000 | -81.9% | 4,200 | -86.3% | 0.08% | -76.5% |
| Q3 2017 | $1,533,000 | -64.8% | 30,600 | -67.5% | 0.36% | -63.7% |
| Q2 2017 | $4,356,000 | -65.6% | 94,118 | -73.7% | 0.99% | +29.4% |
| Q1 2017 | $12,658,000 | +20996.7% | 358,493 | +7316.1% | 0.77% | +38300.0% |
| Q4 2016 | $60,000 | +172.7% | 4,834 | +202.1% | 0.00% | +100.0% |
| Q3 2016 | $22,000 | +633.3% | 1,600 | +433.3% | 0.00% | – |
| Q2 2016 | $3,000 | -97.9% | 300 | -96.4% | 0.00% | -100.0% |
| Q1 2016 | $141,000 | +182.0% | 8,300 | +267.1% | 0.01% | +266.7% |
| Q4 2015 | $50,000 | +316.7% | 2,261 | +352.2% | 0.00% | +200.0% |
| Q3 2015 | $12,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |